The Rest Is Science The Rest Is Science

Something Weird Is Going On With Placebos

Oct 11, 2026 · 49m

Summary

Hannah Fry and Michael Stevens explore the growing effectiveness of placebos, particularly in the US, driven by longer clinical trials and pharmaceutical marketing. They discuss the "Tinkerbell effect," where belief enhances outcomes, and the "reverse Tinkerbell effect," where confidence in safety leads to riskier behavior. The episode covers the distinction between placebos and nocebos, the power of medical ritual, and why "doing something" often matters more than the specific treatment.

Topics discussed

Intro: The rising effectiveness of placebos in America Sponsor segments: Cancer Research UK, Carvana, LinkedIn Defining placebo vs. varum and the McGill study Data: Pain relief drugs losing efficacy to placebos Antidepressants: 80% of efficacy attributed to placebo Why US placebos are stronger: Rituals and advertising Pain as a brain-constructed reality and signal for help The 'doing something' effect and social support Harvard migraine study: Uncertainty and hypervigilance The ethics of prescribing placebos and lifestyle changes Prostate and thyroid cancer: The cost of 'doing something' The role of medical ritual, glamour, and presentation Sponsor segment: Checkout.com Nocebo effect and the fake laser pain experiment The Tinkerbell effect: Belief creating reality in schools Reverse Tinkerbell: Safety, traffic lights, and fake controls TV production tricks: Strawberry filters and mayonnaise commercials Conclusion: Stock markets and the power of collective belief Sponsor segment: Apple Watch
Listen ad-free on Castria